Insiders · VZ

Kyle Malady

EVP and Group CEO-VZ Business at Verizon Communications Inc (VZ)

Kyle Malady has filed 194 insider reports with the SEC since January 2021, as EVP and Group CEO-VZ Business at Verizon Communications Inc (VZ) and director at Dexcom Inc (DXCM). In the last 12 months Kyle Malady sold $530K of stock on the open market. The latest filing, on November 20, 2026, reports grant or award at Verizon Communications Inc (VZ).

Filings
194
Companies
2
Bought on market
None
Sold on market
$7.4M

Companies where Kyle Malady is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Verizon Communications Inc logo
VZ
Verizon Communications Inc
EVP and Group CEO-VZ Business95,566$7.34M$46.48Nov 20, 2026
Dexcom Inc logo
DXCM
Dexcom Inc
Director28,242$53.9K$79.32Jun 1, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Kyle Malady with

Other insiders at the same companies

Questions about Kyle Malady

What is Kyle Malady's role at Verizon Communications Inc?
Kyle Malady reports to the SEC as EVP and Group CEO-VZ Business at Verizon Communications Inc (VZ), according to the latest filing on November 20, 2026. Kyle Malady has also filed as director at Dexcom Inc (DXCM).
How many shares does Kyle Malady own?
After the latest filing that states it, Kyle Malady directly owned 95,566 shares of Verizon Communications Inc (VZ) and 28,242 shares of Dexcom Inc (DXCM). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Kyle Malady bought or sold stock recently?
The most recent open-market sale was on November 17, 2026: sold 1,100 shares of Verizon Communications Inc (VZ) for $50.7K at an average of $46.06.
How do I get alerts when Kyle Malady files?
Follow Kyle Malady on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Kyle Malady filed 14 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Kyle Malady (SEC CIK 0001760581). Totals count each trade once, skipping amendments whose original is on file, from Jan 25, 2021 on. View on SEC EDGAR · Get this as JSON